YOSEMITE and RHINE

YOSEMITE and RHINE

Purpose: Faricimab is a novel anti–angiopoietin-2 and anti–vascular endothelial growth factor (VEGF) bispecific antibody with high affinities and specificities for both VEGF and angiopoietin-2. It is postulated that targeting angiogenic factors and inflammatory pathways in addition to the VEGF pathw...

Full description

Bibliographic Details
Main Authors: Nicole Eter, MD, PhD, Rishi P. Singh, MD, Francis Abreu, PhD, Kemal Asik, PhD, Karen Basu, PhD, Caroline Baumal, MD, Andrew Chang, PhD, Karl G. Csaky, MD, Zdenka Haskova, MD, PhD, Hugh Lin, MD, Carlos Quezada Ruiz, MD, Paisan Ruamviboonsuk, MD, David Silverman, MSc, MRCOphth, Charles C. Wykoff, MD, PhD, Jeffrey R. Willis, MD, PhD
Format: Article
Language:English
Published: Elsevier 2022-03-01
Series:Ophthalmology Science
Subjects:
Adjustable dosing
Angiopoietin-2
Anti–vascular endothelial growth factor
Bispecific antibody
Diabetic macular edema
Faricimab
Online Access:http://www.sciencedirect.com/science/article/pii/S2666914521001093

Internet

http://www.sciencedirect.com/science/article/pii/S2666914521001093

Similar Items